Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

562 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An International, Retrospective Study of Off-Label Biologic Use in the Treatment of Hypereosinophilic Syndromes.
Chen MM, Roufosse F, Wang SA, Verstovsek S, Durrani SR, Rothenberg ME, Pongdee T, Butterfield J, Lax T, Wechsler ME, Stein ML, Ogbogu PU, Kahwash BM, Mathur SK, Simon D, Akuthota P, Holland N, Wetzler L, Ware JM, Guo C, Fay MP, Khoury P, Klion AD, Bochner BS. Chen MM, et al. Among authors: rothenberg me. J Allergy Clin Immunol Pract. 2022 May;10(5):1217-1228.e3. doi: 10.1016/j.jaip.2022.02.006. Epub 2022 Feb 15. J Allergy Clin Immunol Pract. 2022. PMID: 35181548 Free PMC article.
Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes.
Garrett JK, Jameson SC, Thomson B, Collins MH, Wagoner LE, Freese DK, Beck LA, Boyce JA, Filipovich AH, Villanueva JM, Sutton SA, Assa'ad AH, Rothenberg ME. Garrett JK, et al. Among authors: rothenberg me. J Allergy Clin Immunol. 2004 Jan;113(1):115-9. doi: 10.1016/j.jaci.2003.10.049. Epub 2003 Dec 12. J Allergy Clin Immunol. 2004. PMID: 14699394 Clinical Trial.
Anti-IL-5 and hypereosinophilic syndromes.
Sutton SA, Assa'ad AH, Rothenberg ME. Sutton SA, et al. Among authors: rothenberg me. Clin Immunol. 2005 Apr;115(1):51-60. doi: 10.1016/j.clim.2005.02.006. Clin Immunol. 2005. PMID: 15870021 Review.
Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report.
Klion AD, Bochner BS, Gleich GJ, Nutman TB, Rothenberg ME, Simon HU, Wechsler ME, Weller PF; The Hypereosinophilic Syndromes Working Group. Klion AD, et al. Among authors: rothenberg me. J Allergy Clin Immunol. 2006 Jun;117(6):1292-302. doi: 10.1016/j.jaci.2006.02.042. Epub 2006 May 3. J Allergy Clin Immunol. 2006. PMID: 16750989
Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis.
Stein ML, Collins MH, Villanueva JM, Kushner JP, Putnam PE, Buckmeier BK, Filipovich AH, Assa'ad AH, Rothenberg ME. Stein ML, et al. Among authors: rothenberg me. J Allergy Clin Immunol. 2006 Dec;118(6):1312-9. doi: 10.1016/j.jaci.2006.09.007. Epub 2006 Nov 7. J Allergy Clin Immunol. 2006. PMID: 17157662 Clinical Trial.
Treatment of patients with the hypereosinophilic syndrome with mepolizumab.
Rothenberg ME, Klion AD, Roufosse FE, Kahn JE, Weller PF, Simon HU, Schwartz LB, Rosenwasser LJ, Ring J, Griffin EF, Haig AE, Frewer PI, Parkin JM, Gleich GJ; Mepolizumab HES Study Group. Rothenberg ME, et al. N Engl J Med. 2008 Mar 20;358(12):1215-28. doi: 10.1056/NEJMoa070812. Epub 2008 Mar 16. N Engl J Med. 2008. PMID: 18344568 Free article. Clinical Trial.
562 results